BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21670194)

  • 1. A retrospective study of those histopathologic parameters predictive of invasion of the lymphatic system by canine mammary carcinomas.
    Rasotto R; Zappulli V; Castagnaro M; Goldschmidt MH
    Vet Pathol; 2012 Mar; 49(2):330-40. PubMed ID: 21670194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of histological grading in noninflammatory canine mammary carcinomas in a prospective study with two-year follow-up: relationship with clinical and histological characteristics.
    Peña L; De Andrés PJ; Clemente M; Cuesta P; Pérez-Alenza MD
    Vet Pathol; 2013 Jan; 50(1):94-105. PubMed ID: 22688585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of a new histological and molecular-based classification of canine mammary neoplasia.
    Im KS; Kim NH; Lim HY; Kim HW; Shin JI; Sur JH
    Vet Pathol; 2014 May; 51(3):549-59. PubMed ID: 24003019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histological grading and prognosis in dogs with mammary carcinomas: application of a human grading method.
    Karayannopoulou M; Kaldrymidou E; Constantinidis TC; Dessiris A
    J Comp Pathol; 2005 Nov; 133(4):246-52. PubMed ID: 16202421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification and grading of canine mammary tumors.
    Goldschmidt M; Peña L; Rasotto R; Zappulli V
    Vet Pathol; 2011 Jan; 48(1):117-31. PubMed ID: 21266722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear pleomorphism: role in grading and prognosis of canine mammary carcinomas.
    Santos M; Correia-Gomes C; Santos A; de Matos A; Rocha E; Lopes C; Pereira PD
    Vet J; 2014 Jun; 200(3):426-33. PubMed ID: 24745769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canine Mammary Tumors: Comparison of Classification and Grading Methods in a Survival Study.
    Canadas A; França M; Pereira C; Vilaça R; Vilhena H; Tinoco F; Silva MJ; Ribeiro J; Medeiros R; Oliveira P; Dias-Pereira P; Santos M
    Vet Pathol; 2019 Mar; 56(2):208-219. PubMed ID: 30381007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of regional lymph node status in canine mammary carcinomas.
    Szczubiał M; Łopuszynski W
    Vet Comp Oncol; 2011 Dec; 9(4):296-303. PubMed ID: 22077411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interobserver Reproducibility of Histological Grading of Canine Simple Mammary Carcinomas.
    Santos M; Correia-Gomes C; Santos A; de Matos A; Dias-Pereira P; Lopes C
    J Comp Pathol; 2015 Jul; 153(1):22-7. PubMed ID: 25979682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis for canine malignant mammary tumors based on TNM and histologic classification.
    Yamagami T; Kobayashi T; Takahashi K; Sugiyama M
    J Vet Med Sci; 1996 Nov; 58(11):1079-83. PubMed ID: 8959655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral squamous cell carcinoma grading systems--analysis of the best survival predictor.
    Lindenblatt Rde C; Martinez GL; Silva LE; Faria PS; Camisasca DR; Lourenço Sde Q
    J Oral Pathol Med; 2012 Jan; 41(1):34-9. PubMed ID: 21902722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development, anatomy, histology, lymphatic drainage, clinical features, and cell differentiation markers of canine mammary gland neoplasms.
    Sorenmo KU; Rasotto R; Zappulli V; Goldschmidt MH
    Vet Pathol; 2011 Jan; 48(1):85-97. PubMed ID: 21147765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mammary carcinoma in female dogs: a new routine diagnosis by the detection of occult micrometastases in the regional lymph nodes].
    Busch U; Rudolph R
    Berl Munch Tierarztl Wochenschr; 1995 Feb; 108(2):43-6. PubMed ID: 7786275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Significance of Canine Mammary Tumor Histologic Subtypes: An Observational Cohort Study of 229 Cases.
    Rasotto R; Berlato D; Goldschmidt MH; Zappulli V
    Vet Pathol; 2017 Jul; 54(4):571-578. PubMed ID: 28355108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of E-cadherin, P-cadherin and beta-catenin in canine malignant mammary tumours in relation to clinicopathological parameters, proliferation and survival.
    Gama A; Paredes J; Gärtner F; Alves A; Schmitt F
    Vet J; 2008 Jul; 177(1):45-53. PubMed ID: 17631398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Value of Occult Isolated Tumour Cells within Regional Lymph Nodes of Dogs with Malignant Mammary Tumours.
    Coleto AF; Wilson TM; Soares NP; Gundim LF; Castro IP; Guimarães EC; Bandarra MB; Medeiros-Ronchi AA
    J Comp Pathol; 2018 Jan; 158():32-38. PubMed ID: 29422313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HER-2, EGFR, Cox-2 and Ki67 expression in lymph node metastasis of canine mammary carcinomas: Association with clinical-pathological parameters and overall survival.
    Araújo MR; Campos LC; Damasceno KA; Gamba CO; Ferreira E; Cassali GD
    Res Vet Sci; 2016 Jun; 106():121-30. PubMed ID: 27234549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratumoral lymphatics and lymphatic vessel invasion detected by D2-40 are essential for lymph node metastasis in bladder transitional cell carcinoma.
    Ma Y; Hou Y; Liu B; Li X; Yang S; Ma J
    Anat Rec (Hoboken); 2010 Nov; 293(11):1847-54. PubMed ID: 20730866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective analysis of immunohistochemically determined estrogen receptor alpha and progesterone receptor expression and host and tumor factors as predictors of disease-free period in mammary tumors of the dog.
    de Las Mulas JM; Millán Y; Dios R
    Vet Pathol; 2005 Mar; 42(2):200-12. PubMed ID: 15753474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing and testing prognostic bio-scoring systems for canine mammary gland carcinomas.
    Sorenmo KU; Durham AC; Kristiansen V; Pena L; Goldschmidt MH; Stefanovski D
    Vet Comp Oncol; 2019 Dec; 17(4):479-488. PubMed ID: 31099972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.